Cancer News and Research

Latest Cancer News and Research

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

Investigators from around the country came to Sanford-Burnham Medical Research Institute (Sanford-Burnham) on Friday, May 7, to share their knowledge of the burgeoning young field of microRNAs. These small non-coding nucleic acids turn off proteins and have been implicated in viral infection, cancer, cardiovascular disease, HIV and numerous other conditions.

12 May 2010

Updated data from Vical's Phase 2 trial of high-dose Allovectin-7 in metastatic melanoma patients

Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.

12 May 2010

Older women want more information about breast cancer, breast screening: Survey

Most older women want more information about breast cancer and want to continue to be invited to breast screening, according to the results of a survey published in the British Journal of Cancer today.

12 May 2010

Genetic tests represent future of cancer care for women

Important progress is being made in women's health through the use of genetic tests, particularly those that help women detect and treat cancer.

12 May 2010

New report traces origins of 100 companies to federally funded university-based research

How can the United States foster long-term economic growth? A new report suggests that one of the best ways is through investment in the basic research that leads to innovation and job creation. "Sparking Economic Growth: How federally funded university research creates innovation, new companies and jobs" released today by The Science Coalition identifies 100 "success stories" - examples of companies that are the result of federal investments in basic research.

12 May 2010

COTI announces favourable independent pre-IND gap analysis report for novel oncology drug candidate

Critical Outcome Technologies Inc. announced today that it received a favourable Pre-Investigational New Drug (pre-IND) gap analysis report from an independent team that reviewed its novel oncology drug candidate COTI-2. This represents an important milestone as the Company draws closer to a Phase 1 clinical trial.

12 May 2010

Meda acquires European rights to new imiquimod formulation for AK from Graceway Pharmaceuticals

“We have very good experience with Aldara in Europe and we look forward to provide AK patients with a new product with improved tolerability that builds on the efficacy of imiquimod”

12 May 2010

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.

12 May 2010

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.

12 May 2010

Researchers discover molecular mechanism behind smoking cessation effect

The tobacco addiction epidemic is a major public health problem worldwide. Professor Zhao Baolu and his group from the State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences set out to tackle this problem. After 20 years of innovative research, they have developed a novel tea filter to treat cigarette addiction and have discovered the molecular mechanism behind the smoking cessation effect.

12 May 2010

New computer-based tool developed to benefit cancer patients

Cancer patients and doctors are finally getting on the same page about cancer survivorship, thanks to a free new tool that can benefit anyone who has been diagnosed with cancer.

12 May 2010

PharmedOut to host conference to explore influence of pharmaceutical industry on medical education

PharmedOut, an initiative aimed at increasing physician access to unbiased information about drugs, will host a conference to explore the issues of pharmaceutical industry funding on continuing medical education. The conference, "Prescription for Conflict: Should Industry Fund Continuing Medical Education?" will be held June 25, 2010 at Georgetown University.

12 May 2010

OriGene Technologies, ISB to create proteotypic PeptideAtlas and SRM/MRM mass spectrometry standard database

OriGene Technologies, Inc., a leading gene-centric life sciences company, and the Institute for Systems Biology (ISB), announce plans to create a proteotypic PeptideAtlas and develop an SRM/MRM (single reaction monitoring, multiple reaction monitoring) mass spectrometry standard database for 5,000 human proteins. The new collaboration will apply ISB's novel systems biology mass spectrometry expertise to OriGene's large collection of full length human proteins.

12 May 2010

Researchers develop anti-angiogenic molecule SR16388 for treatment of MM

SRI International, an independent nonprofit research and development organization, announced today that researchers have developed an anti-angiogenic molecule SR16388 that has demonstrated preclinical antitumor activity against multiple myeloma.

12 May 2010

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients' blood pressure is closely monitored and controlled, a clinical panel has determined.

12 May 2010

Tensions escalate between Obama administration, health insurers

CQ HealthBeat: "WellPoint CEO Angela Braly is protesting comments President Obama made about how a health insurance company treated women diagnosed with breast cancer. [Her] letter marks another battle in the ongoing clash between the administration and the insurance companies — most prominently WellPoint — that hasn't lessened after enactment of the new health care law" (Norman, 5/10).

12 May 2010

Oncos Therapeutics completes € 4 million investment from HealthCap

Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a € 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding € 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.

12 May 2010

NY public hospital system plans to lay off about 500 workers and other state news

The Wall Street Journal: "New York City's Health & Hospitals Corp., the nation's largest public hospital system, plans to stanch a $1.2 billion budget gap in the next year's budget by laying off about 500 workers and ending contracts with 'a significant number' of physicians, its president said.

12 May 2010

Colorectal cancer screening rates much lower among African Americans: Study

Among African Americans, colorectal cancer is the third most common cause of cancer-related death. With the proper screening, it has a 90 percent cure rate, yet screening rates are much lower among this group than other ethnic groups.

12 May 2010

CEA-Leti launches TARGET-PDT project to increase effectiveness of PDT for treating cancer

CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy for treating cancer by developing a novel nano carrier-based approach.

12 May 2010

Cancer News and Research

Latest Cancer News and Research

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

Updated data from Vical's Phase 2 trial of high-dose Allovectin-7 in metastatic melanoma patients

Older women want more information about breast cancer, breast screening: Survey

Genetic tests represent future of cancer care for women

New report traces origins of 100 companies to federally funded university-based research

COTI announces favourable independent pre-IND gap analysis report for novel oncology drug candidate

Meda acquires European rights to new imiquimod formulation for AK from Graceway Pharmaceuticals

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology

Researchers discover molecular mechanism behind smoking cessation effect

New computer-based tool developed to benefit cancer patients

PharmedOut to host conference to explore influence of pharmaceutical industry on medical education

OriGene Technologies, ISB to create proteotypic PeptideAtlas and SRM/MRM mass spectrometry standard database

Researchers develop anti-angiogenic molecule SR16388 for treatment of MM

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

Tensions escalate between Obama administration, health insurers

Oncos Therapeutics completes € 4 million investment from HealthCap

NY public hospital system plans to lay off about 500 workers and other state news

Colorectal cancer screening rates much lower among African Americans: Study

CEA-Leti launches TARGET-PDT project to increase effectiveness of PDT for treating cancer

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in